PYC — PYC Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$637.44m
- AU$572.24m
- AU$22.86m
- 27
- 16
- 90
- 43
Annual cashflow statement for PYC Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.65 | 3.26 | 6.1 | 9.74 | 21.3 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.75 | -11.8 | -21.8 | -24.4 | -38.6 |
| Capital Expenditures | -0.106 | -0.591 | -0.387 | -0.491 | -0.307 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -13.7 | -14.9 | 33.1 | 0.014 | 0 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -13.8 | -15.5 | 32.7 | -0.477 | -0.307 |
| Financing Cash Flow Items | -1.62 | -2.29 | 0 | -0.976 | -1.57 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 25.1 | 38.6 | -0.182 | 11.4 | 90.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.58 | 11.2 | 10.7 | -13.5 | 51.3 |